A patient on lisinopril/hydrochlorothiazide 320/25 mg and amlodipine 10 mg still has systolic blood pressure in the 150s; what medication can be added?

Add Spironolactone as the Fourth Agent

The next medication to add is spironolactone (or eplerenone), a mineralocorticoid receptor antagonist (MRA), as this patient has resistant hypertension requiring a fourth antihypertensive agent 1.

Clarification on Current Regimen

First, note that the stated dose of "lisinopril-HCTZ 320/25" appears incorrect—lisinopril maximum dose is 80 mg, not 320 mg 2. If this is actually lisinopril 20 mg/HCTZ 25 mg (a common combination), the regimen needs optimization before adding a fourth drug. However, assuming the patient is on maximally-dosed therapy with a RAS blocker, thiazide diuretic, and calcium channel blocker, proceed as follows:

Stepwise Approach for Resistant Hypertension

Step 1: Optimize the Current Three-Drug Regimen

• Ensure the patient is on maximally tolerated doses of all three agents:
  • ACE inhibitor or ARB (lisinopril up to 40 mg daily for hypertension) 2
  • Long-acting calcium channel blocker (amlodipine 10 mg is already maximal)
  • Thiazide-like diuretic (chlorthalidone 12.5-25 mg or indapamide 1.25-2.5 mg preferred over HCTZ) 1

Critical point: If the patient is on HCTZ, substitute chlorthalidone or indapamide before adding a fourth agent, as these thiazide-like diuretics are more potent and maintain efficacy at lower GFR levels (down to 30 mL/min/1.73m²) 1.

Step 2: Exclude Pseudoresistance

Before intensifying therapy:

• Confirm elevated BP with 24-hour ambulatory BP monitoring (or home BP monitoring if unavailable) to exclude white-coat effect 1
• Assess medication adherence
• Ensure dietary sodium restriction (<2400 mg/day) 1

Step 3: Add Mineralocorticoid Receptor Antagonist

Spironolactone is the preferred fourth-line agent for resistant hypertension 1. Start with:

• Spironolactone 25 mg daily, titrating up to 50 mg if needed
• Alternative: Eplerenone if gynecomastia or other side effects occur

Caution: Monitor serum potassium and renal function closely, especially given concurrent ACE inhibitor use. Use with caution if eGFR <30 mL/min/1.73m² 1.

Subsequent Steps if BP Remains Uncontrolled

Step 4: Add Beta-Blocker (if heart rate ≥70 bpm)

• Metoprolol succinate, bisoprolol, or combined α-β-blocker (labetalol, carvedilol) 1
• If contraindicated: central α-agonist (clonidine patch weekly) or once-daily diltiazem 1

Step 5: Add Hydralazine

• Start 25 mg three times daily, titrate to maximum dose 1

Step 6: Consider Minoxidil

• Substitute minoxidil 2.5 mg 2-3 times daily for hydralazine
• Requires concomitant β-blocker and loop diuretic 1
• Consider referral to hypertension specialist at this stage

Key Pitfalls to Avoid

1. Don't add a fourth drug without optimizing the diuretic: HCTZ is less effective than chlorthalidone/indapamide 1
2. Monitor electrolytes: Adding spironolactone to an ACE inhibitor increases hyperkalemia risk—check potassium within 1-2 weeks
3. Confirm true resistance: Up to 30% of "resistant" hypertension is white-coat effect or nonadherence 1
4. Screen for secondary causes: Consider primary aldosteronism, renal artery stenosis, obstructive sleep apnea if BP remains refractory 1

The 2018 AHA Scientific Statement on resistant hypertension provides this algorithmic approach based on extensive clinical evidence, with spironolactone demonstrating superior efficacy as the fourth agent in multiple trials 1.